The role of immunotherapy in hepatocellular carcinoma
Immunotherapy has revolutionized the treatment of hepatocellular carcinoma. Researchers from the Hospital Clínic-IDIBAPS have published a review in...
Immunotherapy has revolutionized the treatment of hepatocellular carcinoma. Researchers from the Hospital Clínic-IDIBAPS have published a review in...
Dr. Josep Baselga, an internationally renowned medical oncologist, died of this degenerative disease on 21 March 2021. The meeting was attended by...
The study shows how the average life of the virus is drastically reduced, in transplanted patients and cell cultures alike.
The inhibition of this molecule, in addition to reducing the predisposition towards developing the disease, also reduces the alteration of the micr...
A study conducted at Hospital Clínic analysed the genetic profile of more than 300 patients with solid tumours using a liquid biopsy blood test, re...
The Hospital Clínic-IDIBAPS has developed the first CAR T-cell therapy in Europe to treat multiple myeloma, the second most common type of blood ca...
The researcher has received a runner’s-up prize in the Dr. Font Prize category, which recognises the best research articles published, with potenti...
Mediterranean diet or mindfulness-based stress reduction interventions during pregnancy reduce the prevalence of low birth weight by 29-36% as well...
On Friday, 26 November, the dissemination seminar "Immunotherapy 2.0 in lymphoma: how to design personalized therapies" for patients and relatives...
Interview with Dr Maria Reig, head of the Hepatic Oncology Unit